Weighted Average Number of Shares Outstanding, Basic of TherapeuticsMD, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: TherapeuticsMD, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
TherapeuticsMD, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 11,574,000, a 0.36% increase year-over-year.
TherapeuticsMD, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 11,532,000, a 10% increase from 2023.
TherapeuticsMD, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10,441,000, a 16% increase from 2022.
TherapeuticsMD, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 9,028,000, a 13% increase from 2021.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

TherapeuticsMD, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	11,574,000	+42,000	+0.36%	01 Jul 2025	30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	11,574,000	+42,000	+0.36%	01 Apr 2025	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	11,552,000	+20,000	+0.17%	01 Jan 2025	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q4 2024	11,532,000	+1,091,000	+10%	01 Oct 2024	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q3 2024	11,532,000	+831,000	+7.8%	01 Jul 2024	30 Sep 2024	10-Q	12 Nov 2025	2025	Q3
Q2 2024	11,532,000	+1,313,000	+13%	01 Apr 2024	30 Jun 2024	10-Q	12 Aug 2025	2025	Q2
Q1 2024	11,532,000	+1,778,000	+18%	01 Jan 2024	31 Mar 2024	10-Q	13 May 2025	2025	Q1
Q4 2023	10,441,000	+1,413,000	+16%	01 Oct 2023	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q3 2023	10,701,000	+1,440,000	+16%	01 Jul 2023	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	10,219,000	+1,469,000	+17%	01 Apr 2023	30 Jun 2023	10-Q	12 Aug 2024	2024	Q2
Q1 2023	9,754,000	+1,140,000	+13%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	9,028,000	+1,068,000	+13%	01 Oct 2022	31 Dec 2022	10-K	29 Mar 2024	2023	FY
Q3 2022	9,261,000	+817,000	+9.7%	01 Jul 2022	30 Sep 2022	10-Q	14 Nov 2023	2023	Q3
Q2 2022	8,750,000	+869,000	+11%	01 Apr 2022	30 Jun 2022	10-Q	14 Aug 2023	2023	Q2
Q1 2022	8,614,000	+1,669,000	+24%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q4 2021	7,960,000	-267,689,000	-97%	01 Oct 2021	31 Dec 2021	10-K	07 Apr 2023	2022	FY
Q3 2021	8,444,000	-264,121,000	-97%	01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021	7,881,000	-263,995,000	-97%	01 Apr 2021	30 Jun 2021	10-Q	15 Aug 2022	2022	Q2
Q1 2021	6,945,000	-264,515,000	-97%	01 Jan 2021	31 Mar 2021	10-Q	16 May 2022	2022	Q1
Q4 2020	275,649,000			01 Oct 2020	31 Dec 2020	10-K	23 Mar 2022	2021	FY
Q3 2020	272,565,000			01 Jul 2020	30 Sep 2020	10-Q	12 Nov 2021	2021	Q3
Q2 2020	271,876,000			01 Apr 2020	30 Jun 2020	10-Q	04 Aug 2021	2021	Q2
Q1 2020	271,460,000			01 Jan 2020	31 Mar 2020	10-Q	06 May 2021	2021	Q1

TherapeuticsMD, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	11,532,000	+1,091,000	+10%	01 Jan 2024	31 Dec 2024	10-K	27 Mar 2025	2024	FY
2023	10,441,000	+1,413,000	+16%	01 Jan 2023	31 Dec 2023	10-K	27 Mar 2025	2024	FY
2022	9,028,000	+1,068,000	+13%	01 Jan 2022	31 Dec 2022	10-K	29 Mar 2024	2023	FY
2021	7,960,000	-267,689,000	-97%	01 Jan 2021	31 Dec 2021	10-K	07 Apr 2023	2022	FY
2020	275,649,000	+29,296,000	+12%	01 Jan 2020	31 Dec 2020	10-K	23 Mar 2022	2021	FY
2019	246,353,000			01 Jan 2019	31 Dec 2019	10-K	23 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.